Bioplatforms Australia News

National Synthetic Biology scoping study – Adelaide, Perth and Canberra consultations

 

In the May 2018 budget, the Commonwealth Government announced its long-term investment in support of the Australian Government National Research Infrastructure Roadmap.

The Investment Plan includes funding for a scoping study to progress work in Synthetic Biology. Bioplatforms Australia, with an expert working panel, is conducting an open forum for researchers and other stakeholders to clarify specific needs and gaps in infrastructure requirements for innovations in this field.

 

Bioplatforms Australia is visiting most capital cities in the coming months and we invite you to attend the event that is the most convenient for you.

  • The Adelaide consultation event will be held at The Australian Wine Research Institute (Hartley Grove, Urrbrae, SA 5064) on Monday 11th February 2019, 11am to 12:30pm. Register to the Adelaide consultation event through the dedicated EventBrite page to ensure that numbers can be adequately accommodated.
  • The Perth consultation event will be held at The University of Western Australia (Bayliss Lecture Theatre G33, Bayliss Building, 35 Stirling Highway, Crawley, WA 6009) on Tuesday 12th February 2019, 9:00 am to 10:30 am (AWST). Register to the Perth consultation event through the dedicated EventBrite page to ensure that numbers can be adequately accommodated.
  • The Canberra consultation event will be held at the Australian National University (Mills Room, ANU Chancellery, Building #10, 10 East Road, Canberra, ACT 0200) on Tuesday 26th February 2019, 11:30 am – 1:00 pm AEDT. Register to the Canberra consultation event through the dedicated EventBrite page to ensure that numbers can be adequately accommodated.

 

Please find the National Synthetic Biology scoping study introductory presentation slides here 

 

Contact:
Natalie Curach | ncurach@bioplatforms.com

Synthetic Biology Scoping

Register to the events here: Adelaide, Perth, Canberra

News and Media

Latest Bioplatforms News and Media

News Signup

Bioplatforms Australia

+61 0410 538 648

agilbert@bioplatforms.com